<DOC>
	<DOC>NCT02227758</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term safety and performance of neurostimulation for the treatment of intractable chronic migraine as well as to detect infrequent complications or problems only apparent in "real-world" practice</brief_summary>
	<brief_title>Peripheral Nerve Stimulation Registry for Intractable Migraine Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Patient is 18 years of age or older. Patient has signed and received a copy of the Informed Consent form; Patient has been implanted with a St. Jude Medical CE approved implantable neurostimulation system for the treatment of intractable chronic migraine: Patient diagnosed with chronic migraine (15 or more days per month with headache lasting at least 4 hours per day) Patient has failed three or more preventative drugs for treatment of their migraine Patient has at least moderate disability determined using a validated migraine disability instrument [e.g., MIDAS &gt;11 or HIT6 &gt;56]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>